New US administration's move on H-1B visas and protectionist rhetoric are bad news for India's exports, especially from the information technology sector.

Finance Minister Arun Jaitley on Wednesday presented Union Budget 2017-18 in Lok Sabha. 

The year 2016 experienced innovations and developments in the insurance industry that brought changes in the sector aimed towards benefiting the customers. The opening of e-insurance account is one such example that will help the customers in the long run.

It needs to be seen whether the government takes a populist approach or a business friendly and growth oriented approach. Here are some of the industry expectations particularly from income tax perspective from this year's budget.

We give you tips to choose mutual funds that have the best chance of giving decent returns next year.

India stock market failed to surpass 2015 high of 9119 and drifted towards 6825 mark just before the Union Budget 2016. Going forward as market failed to deliver major gains in the last year, so potential of performance is rising in equity market amid big-bang reform by the government. We look at stocks to watch out for in 2017.

One of the earliest diagnoses made by Sun Pharma in the run-up to the Ranbaxy acquisition was that since the entire management was focusing on resolving the US FDA's negative observations, there was a lack of focus towards expanding the business.

Information might be free. Developing breakthrough compression algorithms and planting transoceanic fibre optic lines is not.

On June 20, around 3 pm, a tweet from the Twitter handle of the Prime Minister's Office (PMO) made a big claim - India has become the most open economy in the world for foreign direct investment (FDI).

Currently, FDI up to 100 per cent is permitted in new projects in the pharmaceutical sector, but in brownfield ones-the existing companies-the foreign investment is permitted through FIPB approval.

Some are not sure if the amendments in the policy that are being proposed are being done without an amendment to the Patent Act but through a notification on amendment of rules. There is still need for clarity on this.

Net profit was Rs 74.6 crore for the quarter against Rs 518.9 crore during the corresponding period last fiscal. Total income also declined by three percent to Rs 3,756.2 crore against Rs 3,870.4 crore during the same period in 2014-15.

Since the past eight months the merged entity has been trading on the Bombay Stock Exchange, nervous investors have been asking two questions - is Shangvi's magic fading? Or, is the slump just a small hitch in Sun's glorious journey over the past one decade?

Developed markets together now contribute 48% to Lupin's revenue (the bulk, no doubt, coming from the US) and emerging markets another 19%, while the domestic market's share has shrunk to 26 per cent from 31 per cent five years ago.

The average price of cut and polished diamonds have been falling steadily whereas the prices of roughs remain high, making the whole business seemingly unsustainable.

Mylan CEO Heather Bresch says India has been doing a pretty good job with its tax-free development zones. Your CSR model is something the rest of the world should follow. It is a great thing to give back to the country, especially when you are developing.

Excluding India, emerging markets account for about a quarter of Glenmark's total sales, and have been a driver of margin growth in the last few years.

In the calendar year 2015 there have been mergers and acquisitions (M&A) worth $110 billion which is on track to exceed last year's record M&A of $140 billion, Jefferies said.

In trading so far this year, Lupin has climbed 32 per cent, Dr. Reddy's 31 per cent, Glenmark Pharmaceuticals 42 per cent and Wockhardt 29 per cent.

The Indian drug firms have joined the global fight against antibiotic-resistant bacteria. The good news is that they are steadily moving ahead.